Add time:07/25/2019         Source:sciencedirect.com

Objective.A phase II study was conducted to determine the efficacy of single agent flavopiridol therapy in patients with recurrent or persistent endometrial adenocarcinoma refractory to established treatments.

We also recommend Trading Suppliers and Manufacturers of FLAVOPIRIDOL HYDROCHLORIDE (cas 131740-09-5). Pls Click Website Link as below: cas 131740-09-5 suppliers